bei Google ScholarTitelangaben
Zimmermann, Paul ; Sourij, Harald ; Aberer, Felix ; Rilstone, Sian ; Schierbauer, Janis ; Moser, Othmar:
SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?
In: Journal of Cardiovascular Development and Disease.
Bd. 10
(2023)
Heft 12
.
- 478.
ISSN 2308-3425
DOI: https://doi.org/10.3390/jcdd10120478
Abstract
The coronavirus disease (COVID)-19 has turned into a pandemic causing a global public health crisis. While acute COVID-19 mainly affects the respiratory system and can cause acute respiratory distress syndrome, an association with persistent inflammatory stress affecting different organ systems has been elucidated in long COVID syndrome (LCS). Increased severity and mortality rates have been reported due to cardiophysiological and metabolic systemic disorders as well as multiorgan failure in COVID-19, additionally accompanied by chronic dyspnea and fatigue in LCS. Hence, novel therapies have been tested to improve the outcomes of LCS of which one potential candidate might be sodium–glucose cotransporter 2 (SGLT2) inhibitors. The aim of this narrative review was to discuss rationales for investigating SGLT2 inhibitor therapy in people suffering from LCS. In this regard, we discuss their potential positive effects—next to the well described “cardio-renal-metabolic” conditions—with a focus on potential anti-inflammatory and beneficial systemic effects in LCS. However, potential beneficial as well as potential disadvantageous effects of SGLT2 inhibitors on the prevalence and long-term outcomes of COVID-19 will need to be established in ongoing research.
Weitere Angaben
| Publikationsform: | Artikel in einer Zeitschrift |
|---|---|
| Begutachteter Beitrag: | Ja |
| Keywords: | coronavirus disease (COVID)-19; long COVID syndrome; sodium–glucose cotransporter 2 inhibitors; SGLT2 inhibitors; cytokine storm; cardiovascular disorders; long COVID and cardiovascular sequelae |
| Institutionen der Universität: | Fakultäten > Kulturwissenschaftliche Fakultät > Institut für Sportwissenschaft > Lehrstuhl Exercise Physiology > Lehrstuhl Exercise Physiology - Univ.-Prof. Dr. Othmar Moser |
| Titel an der UBT entstanden: | Ja |
| Themengebiete aus DDC: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
| Eingestellt am: | 07 Feb 2024 06:12 |
| Letzte Änderung: | 07 Feb 2024 06:12 |
| URI: | https://eref.uni-bayreuth.de/id/eprint/88497 |